142 related articles for article (PubMed ID: 22133320)
21. HLA-B∗ 1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population.
Aggarwal R; Sharma M; Modi M; Garg VK; Salaria M
Hum Immunol; 2014 Nov; 75(11):1120-2. PubMed ID: 25305458
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine-induced toxic epidermal necrolysis: the importance of HLA-B*1502 testing in at-risk populations prior to therapy initiation.
Sargent B; Juhasz MLW; Joe VC; Lee BA; Rojek NW
Int J Dermatol; 2021 Jul; 60(7):907-908. PubMed ID: 33608873
[No Abstract] [Full Text] [Related]
23. Carbamazepine-induced toxic epidermal necrolysis in a patient despite testing negative for HLA B*15:02 allele.
Jiang B; Oh CC; Tan KW; Lee HY
Ann Acad Med Singap; 2021 Mar; 50(3):258-260. PubMed ID: 33855323
[No Abstract] [Full Text] [Related]
24. Are carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis more common in nonepileptic patients?
Dhar S; Todi SK
Dermatology; 1999; 199(2):194. PubMed ID: 10559602
[No Abstract] [Full Text] [Related]
25. Carbamazepine-modified HLA-A*24:02-bound peptidome: Implication of CORO1A in skin rash.
Min F; Fan C; Zeng Y; He N; Zeng T; Qin B; Shi Y
Int Immunopharmacol; 2022 Aug; 109():108804. PubMed ID: 35526384
[TBL] [Abstract][Full Text] [Related]
26. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
[TBL] [Abstract][Full Text] [Related]
27. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
Wu XT; Hu FY; An DM; Yan B; Jiang X; Kwan P; Stefan H; Zhou D
Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
[TBL] [Abstract][Full Text] [Related]
28. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
29. Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.
Fernando SL; Broadfoot AJ
CMAJ; 2010 Mar; 182(5):476-80. PubMed ID: 19933789
[No Abstract] [Full Text] [Related]
30. HLA-B*1502 screening and toxic effects of carbamazepine.
Phillips EJ; Mallal SA
N Engl J Med; 2011 Aug; 365(7):672; author reply 673. PubMed ID: 21848472
[No Abstract] [Full Text] [Related]
31. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
Pirmohamed M; Ostrov DA; Park BK
J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050
[TBL] [Abstract][Full Text] [Related]
32. HLA-B*1502 screening and toxic effects of carbamazepine.
Liao WP; Shi YW; Min FL
N Engl J Med; 2011 Aug; 365(7):672-3; author reply 673. PubMed ID: 21848471
[No Abstract] [Full Text] [Related]
33. Pharmacogenetics of drug hypersensitivity.
Phillips EJ; Mallal SA
Pharmacogenomics; 2010 Jul; 11(7):973-87. PubMed ID: 20602616
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of toxic epidermal necrolysis.
Lee MT; Hung SI; Wei CY; Chen YT
Expert Opin Pharmacother; 2010 Sep; 11(13):2153-62. PubMed ID: 20536296
[TBL] [Abstract][Full Text] [Related]
35. Genetic basis for idiosyncratic reactions to antiepileptic drugs.
Franciotta D; Kwan P; Perucca E
Curr Opin Neurol; 2009 Apr; 22(2):144-9. PubMed ID: 19262378
[TBL] [Abstract][Full Text] [Related]
36. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.
Wang Q; Zhou JQ; Zhou LM; Chen ZY; Fang ZY; Chen SD; Yang LB; Cai XD; Dai QL; Hong H; Wang HX
Seizure; 2011 Jul; 20(6):446-8. PubMed ID: 21397523
[TBL] [Abstract][Full Text] [Related]
37. Coupling Genotyping and Computational Modeling in Prediction of Anti-epileptic Drugs that cause Stevens Johnson Syndrome and Toxic Epidermal Necrolysis for Carrier of HLA-B*15:02.
Teh LK; Selvaraj M; Bannur Z; Ismail MI; Rafia H; Law WC; Sapuan S; Puvanarajah S; Ali PS; Salleh MZ
J Pharm Pharm Sci; 2016; 19(1):147-60. PubMed ID: 27096699
[TBL] [Abstract][Full Text] [Related]
38. Genetic predisposition of life-threatening antiepileptic-induced skin reactions.
Chung WH; Hung SI; Chen YT
Expert Opin Drug Saf; 2010 Jan; 9(1):15-21. PubMed ID: 20001755
[TBL] [Abstract][Full Text] [Related]
39. T cell-mediated hypersensitivity reactions to drugs.
Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
[TBL] [Abstract][Full Text] [Related]
40. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
Devi K
Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
